HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcium-Calmodulin-Dependent Protein Kinases

A CALMODULIN-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on CALCIUM. A wide range of proteins can act as acceptor, including VIMENTIN; SYNAPSINS; GLYCOGEN SYNTHASE; MYOSIN LIGHT CHAINS; and the MICROTUBULE-ASSOCIATED PROTEINS. (From Enzyme Nomenclature, 1992, p277)
Also Known As:
Calcium-Calmodulin-Dependent Protein Kinases, Multifunctional; Calcium-Calmodulin-Dependent Protein Kinases, Restricted; Calmodulin-Dependent Multiprotein Kinase; Calmodulin-Kinase; Cam-MPK; Multifunctional Calcium-Calmodulin-Dependent Protein Kinases; Restricted Calcium-Calmodulin-Dependent Protein Kinases; Calcium Calmodulin Dependent Protein Kinase; Calcium Calmodulin Dependent Protein Kinases, Multifunctional; Calcium Calmodulin Dependent Protein Kinases, Restricted; Calmodulin Dependent Multiprotein Kinase; Calmodulin Dependent Protein Kinase; Calmodulin Dependent Protein Kinases; Calmodulin Kinase; Cam MPK; Kinase, Calcium-Calmodulin-Dependent Protein; Kinase, Calmodulin-Dependent Protein; Multifunctional Calcium Calmodulin Dependent Protein Kinase; Multifunctional Calcium Calmodulin Dependent Protein Kinases; Multiprotein Kinase, Calmodulin-Dependent; Protein Kinase, Calcium-Calmodulin-Dependent; Protein Kinase, Calmodulin-Dependent; Protein Kinases, Calcium-Calmodulin-Dependent; Protein Kinases, Calmodulin-Dependent; Restricted Calcium Calmodulin Dependent Protein Kinase; Restricted Calcium Calmodulin Dependent Protein Kinases; Ca(2+)-Calmodulin-Dependent Protein Kinase; Calcium-Calmodulin-Dependent Protein Kinase; Calmodulin-Dependent Protein Kinase; Calmodulin-Dependent Protein Kinases; Multifunctional Calcium-Calmodulin-Dependent Protein Kinase; Restricted Calcium-Calmodulin-Dependent Protein Kinase
Networked: 658 relevant articles (13 outcomes, 59 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Anderson, Mark E: 24 articles (01/2020 - 01/2002)
2. Maier, Lars S: 17 articles (08/2017 - 12/2006)
3. Bers, Donald M: 14 articles (12/2021 - 12/2005)
4. Luczak, Elizabeth D: 9 articles (01/2020 - 03/2010)
5. Mohler, Peter J: 9 articles (01/2020 - 09/2007)
6. Wehrens, Xander H T: 9 articles (01/2020 - 07/2009)
7. Hasenfuss, Gerd: 9 articles (01/2019 - 12/2006)
8. Mattiazzi, Alicia: 9 articles (01/2019 - 01/2002)
9. Sossalla, Samuel: 8 articles (10/2020 - 09/2010)
10. Backs, Johannes: 8 articles (05/2017 - 11/2009)

Related Diseases

1. Obesity
2. Type 2 Diabetes Mellitus (MODY)
3. Body Weight (Weight, Body)
10/28/2011 - "The protein analysis in the neonatal brain showed changes in the levels of calcium/calmodulin-dependent protein kinase II (CaMKII), growth associated protein-43 (GAP-43) and synaptophysin following neonatal exposure to PBDE 99 (21 μmol/kg body weight), but not following exposure TBBPA. "
09/01/2010 - "Comparing with young and aged unimpaired animals, aged impaired rats exhibited significant reduction in hippocampal but not cortical cAMP-response element-binding phosphorylation states as well as brain-derived neurotrophic factor messenger RNA and protein expressions, which were accompanied by decreased phosphorylation states of hippocampal extracellular signal-related kinase (42/44) and calcium calmodulin kinase IV. Lotus seedpod supplementation (50 and 100 mg/kg body weight intragastric administration) for 7 weeks significantly reversed all these declines happened in hippocampus except calcium calmodulin kinase IV phosphorylation levels. "
10/12/2017 - "We herein demonstrated that (1) HMF was detectable in the brain 10 and 30 min after its oral administration, (2) orally administered HMF improved chronic unpredictable mild stress (CUMS)-induced pathological conditions, including body weight loss and depressive-like behavior, and CUMS-induced neurochemical changes, such as reduction in BDNF expression, decrease in neurogenesis, and decreased level of phosphorylated calcium-calmodulin-dependent protein kinase II in the hippocampus, and (3) these effects of HMF were inhibited by the pre-administration of U0126, a mitogen-activated protein (MAP) kinase inhibitor. "
4. Ischemia
5. Cardiomegaly (Heart Hypertrophy)

Related Drugs and Biologics

1. Calcium-Calmodulin-Dependent Protein Kinase Type 2
2. Proteins (Proteins, Gene)
3. Brain-Derived Neurotrophic Factor (BDNF)
4. Calcium
5. Phosphotransferases (Kinase)
6. Membrane Lipids
7. Protein Kinases (Protein Kinase)
8. Protein Kinase C
9. Protein Isoforms (Isoforms)
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Oral Administration
2. Electroacupuncture
3. Microspheres (Microsphere)
4. Cardiopulmonary Bypass (Heart-Lung Bypass)
5. Catheters